Rank 27 • AI & Clinical Intelligence
Paige
Develops AI-native diagnostic software and digital pathology tools to assist pathologists in detecting and treating cancer.
Visit website- Signal Score
- 90.1
- Total raised
- $220M
- Stage
- Series C
- Founded
- 2017
- Headquarters
- New York, United States
- Region
- North America
Their signal
As the first company to receive FDA approval for AI pathology, Paige remains at the absolute forefront of digital diagnostic oncology.
Signal Score 90.1editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in AI & Clinical Intelligence
Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.